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Summary
The study included 53 patients with various pathologies of the cornea with prolonged absence of epithelialization of the surface or ulceration. 
Among our patients, the majority (52.8%) had deep ulcers, the second largest group had keratouveitis with ulcers (22.6%).  Herpetic keratitis 
(7.5%) and corneal ulcer in systemic diseases (11.3%) had a relatively smaller incidence.  The patients were divided into 2 groups depending on the 
applied surgical intervention: group I (20 patients – 20 eyes) – patients who underwent a single (simple) coverage of the cornea with lyophilised 
amniotic membrane; group II (33 patients – 33 eyes) – patients, following a double corneal coverage with lyophilised amniotic membrane.  Results 
of treatment in group I: keratouveitis with ulceration (5 patients) – recovery in 2 cases and improvement in 3 cases, keratitis with ulceration (2 
patients) – recovery in 1 case and improvement in 1 case, deep corneal ulcer (9 patients) – recovered in 4 cases and in 5 patients the ulcerative 
defect of the cornea almost epithelized, but maintained a residual infiltration of the stroma and a small swelling of the cornea.  The visual acuity 
increased by 0.3 – 0.4 in comparison with the original data.  After 6 -7 months after surgery, recurrence of herpetic keratitis in 1 case.  Results 
of treatment in group II: keratouveitis with ulceration (7 patients.) – all cases recovered with complete epithelization of ulcers: in 5 cases with 
a transparent and in 2 cases with a “cloudy” opacity, among herpetic keratitis with ulceration (2 patients) were registered 1 recovery and 1 
improvement, deep corneal ulcers (17 patients) recovered in 14 cases by full epithelialization of ulcers with the formation of a local opacity and 
improved in 3 cases.  By the time of withdrawal of the biological coverage the visual acuity in this group increased by 0.5 – 0.7 from the original 
data.  So, it was established that the double coverage of the cornea with amniotic membrane accelerated 2 times the corneal epithelization and the 
resorption of necrotic masses, caused a faster reduction of the inflammatory process, resulted in a transparent epithelization of ulcerous defect 
4 times better and a period of hospitalization shortened by 2.5 times in comparison with the single coverage.
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Результаты покрытия язвенного дефекта роговицы амниотической оболочкой
Под наблюдением находилось 53 пациента с различной патологией роговицы, сопровождающейся длительным отсутствием 
эпителизации поверхности или изъязвлением.  В зависимости от проведенного оперативного вмешательства больные были 
распределены на 2 группы: I группа (20 больных – 20 глаз) – пациенты, которым было проведено кератопокрытие лиофилизированной 
амниотической оболочкой; II группа (33 больных – 33 глаза) – пациенты, после проведенного двойного кератоамнионопокрытия. 
Результаты лечения в I-й группе: кератоувеиты с изъязвлением (5 чел.) восстановились в 2 случаях, улучшения наблюдались в 3 случаях, 
кератиты с изъязвлением (2 чел.) – восстановление в 1 случае и улучшение в 1 случае, глубокие язвы роговицы (9 чел.) восстановились 
в 4 случаях, у 5 пациентов язвенный дефект роговицы почти эпителизировался, но сохранилась остаточная инфильтрация стромы 
и малое набухание роговицы.  Динамика зрительных функций была на 0,3-0,4 выше, чем исходные данные.  Через 6-7 месяцев 
после операции, рецидив герпетического кератита имел место в 1 случае.  Результаты лечения во II-й группе: кератоиридоциклит с 
изъязвлением (7 чел.) и в 7 случаях была полная эпителизация язвы, в 5 случаях с прозрачной и только в 2 случаях с «облаковидным» 
помутнением, герпетический кератит с изъязвлением (2 чел.) – восстановление в 1 и улучшение в 1 случае, глубокие язвы роговицы 
(17 человек) эпителизировались полностью в 14 случаях с образованием местной прозрачности, улучшения отмечались в 3 случаях. 
Острота зрения в момент снятия биологического покрытия увеличилась на 0,5-0,7 от исходных данных.  Таким образом, установлено, 
что двойное покрытие роговицы амниотической мембраной ускоряло в 2 раза эпителизацию роговицы и резорбцию некротических 
масс, обусловило быстрое снижение воспалительного процесса.  Прозрачная эпителизация язвенного дефекта наблюдалась в 4 раза 
чаще, а период госпитализации сократился в 2,5 раза по сравнению с одиночным покрытием.
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Introduction
The inflammatory diseases of the cornea occupy about 
20% of the overall incidence of eye morbidity, of which the 
most severe are herpes, abscesses, and keratitis that occurs 
against a background of systemic diseases of the body [1, 4].
Treatment of patients with inflammatory diseases of 
the cornea, accompanied by violation of the integrity of 
the epithelium, is one of the most difficult problems in 
modern ophthalmology.  Very often these inflammatory 
processes have a prolonged or recurrent nature.  Various 
methods of antibacterial, enzymatic, catalytic regeneration 
therapy do not always have the necessary therapeutic effect 
[1, 2, 3].  Failure of medical therapy justifies the need to 
develop new methods of effective surgical treatment of 
ulcerative processes of the cornea.  Of the existing methods 
of treatment of diseases of the cornea, we focused on the 
curative biological coverage with amniotic membrane, 
which is motivated by the amniotic membrane’s unique 
antibacterial, antiviral, immunosuppressive, protective and 
antihypoxic properties [5, 6].
Aim of the study – to examine the effectiveness of biolo-
gical corneal coverage with amniotic membrane in patients 
with long-lasting keratitis.
Material and methods
The study included 53 patients with various pathologies 
of the cornea with prolonged absence of epithelialization of 
the surface or ulceration.  Patients’ age ranged from 22 to 73 
years, the average age was 65.5 ± 3.8 years.
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The bio-microscopic examination of the patients showed 
the presence of hyperemia and edema of the conjunctiva 
in 78.5%, pericorneal or mixed injection of the eyeball was 
observed in 100% of cases.  Different shape, color, depth and 
localized corneal infiltrates were detected in 68.6% cases, ede-
ma of the stroma of the iris in 18.6% and hypopion in 18.4% 
cases.  Corneal sensitivity was reduced in 18.6% of cases.  The 
fluorescein probe revealed staining of random degree in 100% 
of cases.  When examining the Schirmer test of tear production 
in these patients, its decrease was noted in 6 patients (15.7% 
of cases), in other cases it increased.
Due to the failure of medical therapy the patients under-
went the surgical treatment of biologic corneal coverage with 
amniotic membrane (Fig. 1, 2).
Depending on the surgical intervention the patients were 
divided into 2 groups:
• Group I (20 patients – 20 eyes) underwent single corneal 
coverage with lyophilized amniotic membrane;
• Group II (33 patients – 33 eyes) followed double corneal 
coverage with lyophilized amniotic membrane.
The assignation of the patients by pathology is shown in 
table 1.
Table 1
The assignation of the patients by pathology
Pathology
Number of patients  
(number of eyes)
Total  
(n = 53)
Group I  
(n = 20)
Group II  
(n = 33)
Kerato-uveitis with corneal ulcer 12 5 7
Herpetic keratitis with ulceration 4 2 2
Trophic keratitis 3 1 2
Deep corneal ulcers 28 9 19
Corneal ulcer in systemic diseases 6 3 3
Among our patients, the majority (52.8%) had deep ulcers, 
the second largest group had keratouveitis with ulcers (22.6%). 
Herpetic keratitis (7.5%) and corneal ulcer in systemic diseases 
(11.3%) had a relatively smaller incidence.
The study did not include the patients with severe purulent 
processes of the cornea, accompanied by perforation of the 
cornea of varying degree.  In these cases it has been recom-
mended the subtotal or total keratoplasty or it was pursued 
alternatively to autokonjunctivoplasty.  Timely execution 
of penetrating corneal transplantation with the necessary 
amount of reconstruction of the anterior segment of the eyes 
in the acute stage of purulent process of the cornea, as at its 
end, makes it possible to save the eye as an organ and to obtain 
an intense therapeutic effect even in the terminal stage of the 
corneal disease.
The assignation of the patients by etiology of the corneal 
disease is shown in table 2.
Table 2
The assignation of the patients  
by etiology of the corneal disease
Etiological factor Number of patients (number of eyes)
Trauma 28
Surgery 3
Herpes infection 4
Contact lenses 3
Diseases of the musculoskeletal apparatus 6
Dry-eye syndrome 4
Unknown etiology 5
Total 53
Accordingly, as set out in table 2, the most frequent of the 
etiological factors of the inflammatory diseases of the eye were 
traumatic (52.8%) and herpetic lesions (7.5%).  The percen-
tage of inflammatory diseases of the cornea with unknown 
etiology was large enough (9.4%), which can be explained 
by the difficulties of differential diagnosis in this group of 
diseases and polymorphism of clinical manifestations of the 
same infection.
Results and discussion
The most frequent complaints of the examined patients in 
both groups were: pain (96%), decreased visual acuity (100%), 
Fig. 1.  Lyophilized amniotic membrane.  
Haemtoxillin-Eosin. x 120.
Fig. 2.  Lyophilized amniotic membrane (natural size).
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photophobia, lacrimation (98.8%), redness of the eyes (100%) 
edema of the eyelids (87%).  The frequency and severity of a 
complaint depended on the form and severity of the disease.
The diagnosis of keratouveitis (12 cases) was determined 
by the presence of corneal syndrome, injection of the eyeball, 
the presence of inflammatory infiltrates in the cornea, hype-
remia and edema of the stroma of the iris with the deposition 
of fibrin on it, opalescence of anterior chamber’s moisture, 
anterior and posterior synechiae.
In 4 cases herpetic keratitis had a recurrent evolution.  It 
was noted the clouding of the deep layers of the cornea with 
ulcer symptoms and Descemet’s membrane folds.
The transition of the purulent infiltrates into corneal ulcers 
with deep defect was observed in 52.8% of cases.  Ulcers of the 
cornea were characterized by the following clinical picture: 
pronounced corneal syndrome, mixed injection of the eyeball, 
corneal neovascularization edema of the endothelium.  In 
patients with deep corneal ulcers most often the ulcerative 
defect, clinically, was 4 - 6 mm wide with a purulent infil-
tration on the bottom and edges of the ulcer with necrosis of 
the epithelium, of different layers of the corneal stroma and 
marked perifocal edema.  Ulcers were located in the middle 
or paracentral in 94% of cases and paralimbal in 6% of cases.
Evolution of the clinical manifestations of the inflammato-
ry process in corneal ulcer depending on the applied surgery 
method is presented in table 3.
Table 3
The evolution of clinical manifestations of the 
inflammatory process in corneal ulcer depending on the 
applied surgery method
Clinical symptome
Surgery method
Simple  
coverage
(group I)  
(n = 20)
Double 
coverage
(group II)  
(n = 33)
Epithelization of cornea, 
days:
beginning
finishing
5.6 ± 0.16
11.0 ± 0.16
3.7 ± 0.15***
6.2 ± 0.17***
Infiltration resorption, 
days:
beginning
finishing
5.1 ± 0.17
8.5 ± 0.16
2.9 ± 0.16***
5.2 ± 0.15***
Resorption of hypopyon, 
days:
beginning
finishing
3.8 ± 0.17
5.5 ± 0.16
1.9 ± 0.17***
3.7 ± 0.17***
Disappearance of inflammation, days 14.5 ± 0.16 8.2 ± 0.17***
Note: *** - р < 0.001 - statistical differences between group I and 
group II.
In all patients, following a biological coverage of the cornea 
using amniotic membrane, the inflammatory process and the 
symptoms of corneal syndrome disappeared.  In group I, there 
were 2 cases of recurrent inflammatory process in 7-8 months 
after treatment.  Thus, all cases of recurrence were provoked 
by herpetic infection.  The results of treatment in the group 
II were stable during the whole period of further observation 
(from 6 to 36 months) after surgery.
In surface processes, as a result of treatment after the 
double coverage of the cornea (group II) translucent, delicate 
corneal opacity was observed in 33.3% of cases (11 people).
Transparent healing corneal defects were noted in 15% of 
cases in patients of group I, while in the group II – transparent 
epithelization was observed in 51.5% of cases.
In both groups, in deeper ulcerative process the outcome 
of the process had varying degrees of intensity of turbidity, 
but in patients following the double coverage with amnion 
membrane the turbidity of the cornea was much less intense, 
these patients were 2, i.e. 22.2% of the patients in this group 
(they later held transcornean keratoplasty), in group I an 
intense turbidity appeared in 47.4% of cases.
The results of the outcome of treatment by application 
of the biological coverage with amniotic membrane (tab. 2) 
varied clearly in the studied groups after the surgery.  Thus, 
in patients who received biological coverage with amniotic 
membrane improvement was observed in 50% of cases, and 
the remaining 50% held an obvious improvement with positive 
dynamics.  After double cover with amnion membrane, com-
plete recovery was obtained, in 93.9% of cases clear positive 
dynamics were observed in the remaining 6.1% of cases.
Double coverage of the corneal ulcer (group II) resulted 
in more rapid normalization of systemic markers of inflam-
mation.  Thus, at the end of the treatment in blood serum 
sialic acid level decreased from 264.2 ± 1.4 to 161.8 ± 2.0 uc 
(p < 0.001), the seromucoid - from 0.367 ± 0.5 to 0.214 ± 0.5 
uc (p < 0.001), the fibrinogen - from 8.4 ± 0.10 to 6.3 ± 0.14 
g/l (р < 0.001).  By day 14 of treatment, C-reactive protein 
concentration decreased from 12.1 ± 0.3 to 8.5 ± 0.4 mcg/ml 
(р < 0.001), but remained 1.5 times higher than the standard 
indices (5.9 ± 0.6 mcg/ml).
In patients of group I, the sialic acid decreased from 262.3 ± 
1.6 to 199.3 ± 1.7 c.u. (p < 0.001), the seromucoid – from 0.361 
± 0.9 to 0.231 ± 0.6 c.u. (p > 0.1), the fibrinogen – from 9.0 ± 
0.20 to 8.8 ± 0.29 g/l (p > 0.1), C-reactive protein concentration 
decreased from 12.6 ± 0.4 to 11.8 ± 0.4 mcg/ml (р > 0.1).
Inflammatory process in corneal ulcers manifested by 
increased systemic concentrations of proinflammatory cyto-
kines (IL-1β, TNFα, IL-8) in the blood serum.  The dynamics 
of the concentrations of cytokines is presented in table 4.
Table 4
The dynamics of the concentrations  
of cytokines in blood (M ± m)
Indices
Groups of patients
Simple coverage 
(Group I) (n = 20)
Double coverage 
(Group II) (n = 33)
IL-1β, pg/ml
initial
after 7 days
after 14 days
      
99.4 ± 6.3 
76.3 ± 4.1*** 
21.3 ± 5.8***
 
95.4 ± 5.8 
82.8 ± 6.1*** 
49.4 ± 4.9***
TNFα, pg/ml
initial
after 7 days
after 14 days
   
87.1 ± 4.3
62.9 ± 5.4***
18.4 ± 5.1***
  
88.5 ± 5.6
71.2 ± 4.8***
31.3 ± 5.3***
IL-8, pg/ml
initial
after 7 days
after 14 days
112.3 ± 5.3
81.9 ± 4.9***
45.7 ± 6.0***
 
110.4 ± 5.3
92.8 ± 4.7***
70.8 ± 6.0***
Note: *** - р < 0.001 - statistical differences between group I and 
group II.
Thus, it was established (tab. 4) that under the influence 
of double coverage, the concentration of interleukin-1β (IL-
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1β) in serum decreased from 99.4 ± 6.3 to 76.3 ± 4.1 pg/ml 
(23.2%, р < 0.001) on the 7th day of treatment, and at the 14th 
day - 4.7 times, reaching the average level of 21.3 ± 5.8 pg/
ml (р < 0.001) in the whole group.  In spite of the veridical 
decrease of IL-1β, the concentration of this cytokine remained 
increased compared to the conditionally healthy individuals 
(8.6 ± 1.5 pg/ml).  Simultaneously with this fact, it was de-
termined that treatment with Bio-R caused the decrease of 
TNFα concentration from 87.1 ± 4.3 to 62.9 ± 5.4 pg/ml (with 
27.8%, р < 0.001) on the 7th day and to 18.4 ± 5.1 pg/ml at day 
14, being about 2.6 times higher compared to its indexes in 
healthy individuals conditioning (7.1 ± 1.1 pg/ml).  At the end 
of the treatment with Bio-R the level of interleukin-8 (IL-8) 
decreased from 112.3 ± 5.3 to 45.7 ± 6.0 pg/ml or 2.5 times 
(р < 0.001) compared with the original data.
In patients of group I, who made the simple coverage of 
the cornea, the concentrations of all proinflammatory cytoki-
nes decreased as well, but were less obvious: IL-1β decreased 
from 95.4 ± 5.8 to 82.8 ± 6.1 pg/ml (13.2%, р < 0.001) at day 
7 of treatment and to 49.4 ± 4.9 pg/ml (р < 0.001) on the 
14th day, i.e. 1.9 times.  Simultaneously, there was a decrease 
in the concentration of TNFα from 88.5 ± 5.6 to 71.2 ± 4.8 
pg/ml (by 19.5%, р < 0.001) to the 7th day and to 31.3 ± 5.3 
pg/ml at day 14 of treatment, while being increased 4.4 times 
compared with its level in healthy persons conditioning (7.1 ± 
1.1 pg/ml).  At the end of the study, patients in group II IL-8 
decreased from 112.3 ± 5.3 to 45.7 ± 6.0 pg/ml or 2.5 times 
(р < 0.001) in comparison with the original data.
The results of treatment for each group separately for 
nosological form of the disease
The criteria for allocation of patients in the group “cured” 
and the group of “improved”.  As “cured” we considered the 
full subsided inflammation, reduction of pain syndrome, 
complete epithelization of the ulcer, the outcome of which 
was a clear cornea and a small superficial corneal opacity, and 
the outcome of deep ulcers - a local turbidity.  The category of 
“improved” - we included the patients with an almost complete 
subsided inflammatory process, but with preservation of the 
residual infiltrate.
The results of treatment in group I
The contact of the amniotic membrane with the cornea 
lasted from 3 to 7 days.
Keratouveitis with ulceration (5 patients) was recovered 
in 2 cases: we have full subsided the symptoms of iridocycli-
tis, epithelization of the ulcer with the formation of a gentle 
“cloudy” opacity.
There was improvement in 3 cases, but there remained 
moderate “roughness” of the epithelium of the cornea, swelling 
of iris and isolated posterior synechiae.
In the cases of keratitis with ulceration (2 patients), reco-
very was observed in 1 case - the corneal and inflammatory 
syndromes have been cropped, there was also a complete 
epithelialization of ulcers, with the formation of semitrans-
parent opacity.
Improvement occurred in 1 case, characterized by almost 
complete epithelization of the ulcer, pronounced eyes injecti-
on, subtotal turbidity in the inflammation area.
Deep corneal ulcer (9 patients) recovered in 4 cases, i.e. 
cropping of the inflammatory process and complete epitheli-
alization of the ulcer was observed.
In 5 patients an ulcerative defect of the cornea almost epi-
thelized, but maintained a residual infiltration of the stroma 
and a small swelling of the cornea.
Visual acuity of patients in this group before and after 
biological coverage reflected in table 5.
Table 5
Dynamics of the visual acuity after biological coverage
Visual acuity Before operation (number of eyes)
After operation 
(number of eyes)
1/∞ р.l.с – 0.01 12 (60%) 1 (5%)
0.02 – 0.04 3 (15%) 2 (10%)
0.05 – 0.07 2 (10%) 1 (5%)
0.08 – 0.1 2 (10%) 10 (50%)
0.2 – 0.4 1 (5%) 4 (20%)
0.5 – 0.7 0 2 (10%)
Total 20 (100%) 20 (100%)
Dynamics of the visual functions amounted to 0.3 – 0.4 
higher than the original data.  After 6 -7 months after surgery, 
recurrence of herpetic keratitis occurred in 1 case.  Deep 
corneal ulcer epithelized with ingrowth of a large number of 
newly formed vessels. Inhibition of existing vascularization 
was not fixed in any case.  In 7 cases (35%) on the background 
of the formed intensive corneal opacity it was recommended 
to execute keratoplasty in terms of 3 to 7 months after the 
coverage with amnion.
The results of treatment in group II
In group II, after the operation of double keratoplasty, the 
contact of amnion with the infected cornea had an average 
of 18 days.
Keratoiritis with ulceration (7 patients): recovery - in 7 
cases, i.e. we observed a complete epithelization of ulcers in 
5 cases with transparent and only in 2 cases with a “cloudy” 
opacity, complete relief of the inflammatory process, the 
disappearance of the corneal and pain syndromes, lack of 
infiltration of the stroma.
Among herpetic keratitis with ulceration (2 patients) 1 
recovery was registered, which marked a complete epithelia-
lization of the cornea with the formation of a tender “cloudy” 
opacity.
Improvement - 1 (deep herpetic corneal ulcer) - after re-
moving the biological cornea coverage we noted incomplete 
subsided inflammation, almost complete epithelization of 
the affected area, and a moderate infiltration of the corneal 
stroma.
In deep corneal ulcers (17 patients) we noted recovery 
in 14 cases, which was characterized by full epithelialization 
of ulcers with the formation of a local opacity, subsiding 
inflammation, disappearance of winking spasm, lacrimation 
and pain.
Improvement was noticed in 3 cases, which, when pro-
nounced positive dynamics, were characterized by the pre-
sence of residual petechial inflammatory infiltrate.
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Visual acuity at the time of removal of the biological 
coverage increased by 0.5 – 0.7 ± 0.06 from the original data.
When viewed after 6 and 12 months, in some patients 
improvement was noted in visual acuity which was at 0.1 – 0.2.
The dynamics of visual functions of patients following a 
double coverage of the cornea with amnion membrane are 
reflected in the table 6.
Таble 6
Dynamics of visual functions of patients following a 
double coverage of the cornea
Visual acuity Before the surgery(number of eyes)
After the surgery
 (number of eyes)
1/∞ р 1.с – 0.01 14 (42.4%) 0
0.02 – 0.04 12 (36.3%) 3 (9.1%)
0.05 – 0.07 3 (9.1%) 2 (6.1%)
0.08 – 0.1 2 (6.1%) 16 (48.5%)
0.2 – 0.4 2 (6.1%) 5 (15.1%)
0.5 – 0.7 0 7 (21.2%)
Total 33 (100%) 33 (100%)
Low visual acuity was observed mainly in elderly patients 
and this was due to the residual corneal opacity, cataract de-
velopment, changes in the retina and optic nerve, destructive 
changes in the vitreous body.
It should be noted that the very next day after surgery, we 
recorded cupping of the cornea syndrome as well as ciliary 
pain and discomfort, which were continuously present before 
the treatment.
The inflammatory process was stopped after 5-7 days, 
which was characterized by the disappearance of eye injection; 
after the biological coverage a significant decrease was noticed 
in the diameter of the deep ulcers and complete epithelializa-
tion in superficial processes.
There was a positive subjective assessment of the treatment 
by the patients.
The patients were examined 3, 6, 12, 18, 24 and 36 months 
after the treatment to confirm the stabilization of the positive 
dynamics in the absence of the phenomena of inflammation.
After eliminating the double biological coverage in all 
cases, the inhibition of vascularization of varying degrees 
was observed. After 1-1.5 months in some patients a con-
tinuation of the, ”clearage” of the newly formed vessels in 
the cornea was registered.
In no case of keratoplasty was there a toxic or allergic 
reaction of the eye to the amnion membrane was registered.
The average period of stay in the hospital of patients with 
inflammatory diseases of the cornea in group 1 was 16.5 ± 
2.4 days, in the II-nd – 7.0 ± 1.5.
On the basis of these studies indications for the double co-
verage of the cornea with amnion membrane were elaborated.
Indications for the double coverage of the cornea are:
- absence of a positive effect on the ongoing conservative 
therapy within 3 days of treatment starting in hospital;
- the progression of the pathological process in the cornea, 
leading to thinning of the cornea;
- long-term non-healing ulcers, which may represent 
an input “gate” for a secondary infection, which may be the 
immediate cause of death of the eyes;
- serious somatic diseases (diabetes, asthma, coronary 
heart disease, hypertension, etc.) are a contraindication for 
conducting more extensive surgeries;
- lack of donor material for the needed surgery.
Conclusions
The following incidence of etiological factors of the corneal 
ulcer were registered: 52.8% - ocular trauma, 7.5% - herpes 
infection, 9.4% - unidentified etiology.
Double coverage of the cornea with amniotic membrane 
doubled the speed of the corneal epithelization and the resor-
ption of necrotic masses, and it caused a faster reduction of the 
inflammatory process in comparison with the single coverage.
Transparent epithelization of ulcerous defect occurred in 
50% of cases in patients who had double coverage and in 12% 
cases of patients who made a simple coverage.
The period of hospitalization in patients who have made 
a double coverage was on average 2.5 times shorter than in 
patients with simple coverage of the cornea.
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